OpenEvidence Soars: 'ChatGPT for Doctors' Secures $12B Valuation!
Analysis
Key Takeaways
- •OpenEvidence, the company behind "ChatGPT for doctors," raised $250 million in a new funding round.
- •The company's valuation has skyrocketed to $12 billion, demonstrating significant growth since October.
- •The funding round was led by Thrive and DST, highlighting investor confidence in AI's medical applications.
“OpenEvidence, which is building “ChatGPT for doctors”, raised $250M led by Thrive and DST at a $12B valuation, up from $6B in October and $1B in February 2025”